Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol-enhanced MRI for Renal Artery Stenosis
NCT05045872Phase 1Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Sep 2021
- Primary completion
- May 2024
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ferumoxytol in renal artery stenosis (RAS), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Degree of renal artery stenosis, Quantitative cortical T2* value and 10 more. Started Sep 2021; status: completed.
02
Drugs
ferumoxytol
03
Conditions
renal artery stenosis (RAS)
Beyond the preview
Go deeper on NCT05045872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05045872.